Al
No verificado

Allurion Technologies, Inc.

Sobre qué escribimos

BiotecnologíaFitnessMaterial médico sanitarioSaludSanidad
12/03/2026
Higiene alimentaria
Industria
Técnica
Comunicación
Sanidad
Fitness
Biotecnología
Software
Salud
Telefonía
Allurion Advances Plan to Regain Listing Compliance
1.00
11/03/2026
Industria
Higiene alimentaria
Técnica
Comunicación
Sanidad
Fitness
Biotecnología
Software
Salud
Telefonía
Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy
1.00
02/03/2026
Comunicación
Material médico sanitario
Higiene alimentaria
Salud
Sanidad
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
1.00
24/02/2026
Finanzas
Higiene alimentaria
Material médico sanitario
Salud
Fitness
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
1.00
23/02/2026
Salud
Higiene alimentaria
Material médico sanitario
Sanidad
Allurion Receives U.S. FDA Approval
1.00
03/02/2026
Biotecnología
Farmacéutica
Fitness
Salud
Mercado laboral
Industria
Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices
1.00
12/01/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Biotecnología
Fitness
Salud
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
1.00
25/11/2025
Salud
Material médico sanitario
Fitness
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Industria
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0